{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Cell Biology",
      "Cell culture",
      "Cell-based Assays",
      "High Throughput Screening",
      "Molecular Biology",
      "Molecular/Chemical Probes"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34841271",
  "DateCompleted": {
    "Year": "2021",
    "Month": "12",
    "Day": "28"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "12",
    "Day": "28"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "11",
        "Day": "22"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "101024",
      "10.1016/j.xpro.2021.101024"
    ],
    "Journal": {
      "ISSN": "2666-1667",
      "JournalIssue": {
        "Volume": "3",
        "Issue": "1",
        "PubDate": {
          "Year": "2022",
          "Month": "Mar",
          "Day": "18"
        }
      },
      "Title": "STAR protocols",
      "ISOAbbreviation": "STAR Protoc"
    },
    "ArticleTitle": "Detection of SARS-CoV-2 spike protein binding to ACE2 in living cells by TR-FRET.",
    "Pagination": {
      "StartPage": "101024",
      "MedlinePgn": "101024"
    },
    "Abstract": {
      "AbstractText": [
        "The SARS-CoV-2 coronavirus infects human cells through the interaction of the viral envelope spike protein (IPR044366) with the human angiotensin-converting enzyme 2 (ACE2), expressed at the surface of target cells. Here, we describe a detailed protocol to measure the binding of the receptor binding domain (RBD) of spike to ACE2 by time-resolved fluorescence resonance energy transfer (TR-FRET). The assay detects the spike/ACE2 interaction in physiologically relevant cellular contexts and is suitable for high-throughput investigation of interfering small-molecule compounds and antibodies. For complete details on the use and execution of this protocol, please refer to Cecon et\u00a0al. (2021)."
      ],
      "CopyrightInformation": "\u00a9 2021 The Author(s)."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 de Paris, Institut Cochin, INSERM, CNRS, 75014 Paris, France."
          }
        ],
        "LastName": "Cecon",
        "ForeName": "Erika",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 de Paris, Institut Cochin, INSERM, CNRS, 75014 Paris, France."
          }
        ],
        "LastName": "Dam",
        "ForeName": "Julie",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 de Paris, Institut Cochin, INSERM, CNRS, 75014 Paris, France."
          }
        ],
        "LastName": "Jockers",
        "ForeName": "Ralf",
        "Initials": "R"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "STAR Protoc",
    "NlmUniqueID": "101769501",
    "ISSNLinking": "2666-1667"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Spike Glycoprotein, Coronavirus"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "spike protein, SARS-CoV-2"
    },
    {
      "RegistryNumber": "EC 3.4.17.23",
      "NameOfSubstance": "ACE2 protein, human"
    },
    {
      "RegistryNumber": "EC 3.4.17.23",
      "NameOfSubstance": "Angiotensin-Converting Enzyme 2"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Angiotensin-Converting Enzyme 2"
    },
    {
      "QualifierName": [
        "immunology",
        "metabolism"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Fluorescence Resonance Energy Transfer"
    },
    {
      "QualifierName": [],
      "DescriptorName": "HEK293 Cells"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Protein Binding"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "immunology",
        "metabolism"
      ],
      "DescriptorName": "Spike Glycoprotein, Coronavirus"
    }
  ],
  "CoiStatement": "The authors declare no competing interests."
}